Brain polysomes are disaggregated in rats given moderate to large doses of d-amphetamine sulfate; this response is rapid in onset, lasts for at least 4-6 hr, and varies with the age of the animal. Pretreatment with a dopamine receptor blocking agent, haloperidol or pimozide, blocks the amphetamine-induced disaggregation.
Rats treated with large single doses of i-dopa (a catecholamine precursor) exhibit a major disaggregation of brain polysomes (1) and a parallel decrease in the net rate of brain protein synthesis (2, 3) . The L-dopa-induced disaggregation of brain polysomes is suppressed in animals pretreated with drugs that block the conversion of dopa to dopamine, or with drugs that block dopamine receptors (4, 5) . Hence, the drug-induced polysome disaggregation may result from a direct action of dopamine on a receptor that controls the intracellular proteinsynthetic apparatus.
Amphetamine, a sympathomimetic agent, acts on the central nervous system to affect locomotor activity (6) (7) (8) (9) , appetite (10) , and thermoregulation (11) (12) (13) (14) ; in high doses, it causes a psychotic reaction in humans that resembles paranoid schizophrenia (15) . Catecholamine-containing brain neurons appear to mediate many of the behavioral and physiological effects of this drug (16) . Relatively little information exists regarding effects of amphetamine on brain protein synthesis. We now report that large doses of d-amphetamine sulfate disaggregate brain polysomes in rats, and that this effect, like that of -dopa, appears to be mediated by dopamine receptors.
MATERIALS AND METHODS
Male albino rats of various ages (Charles River Laboratories, Wilmington, Mass.) were exposed to light from 9 a.m. to 9 p.m. and given free access to food and water. All animals were maintained at ambient temperatures ranging from 20-22'. Animals less than 26 days of age remained with the dam in litters of eight pups; older animals were caged in groups of four for 1 day prior to an experiment. All injections were administered intraperitoneally.
Polysomes were prepared as described (1, 4 (1, 4, 5) .
RESULTS
In the first experiment, 26-day-old animals received 0.9% (w/v) saline vehicle (1 ml/kg) or d-amphetamine sulfate (1.5, 10, 15, or 50 mg/kg, salt weight); they were decapitated 1 hr later. Doses of 10 mg/kg of d-amphetamine or larger disaggregated the brain polysomes; the magnitude of disaggregation, however, was not dose-related (the percentages of total ribosomes represented by polysomes were: 72% with vehicle, 38% with 10 mg/kg, 40% with 15 mg/kg, and 37% with 50 mg/kg). Disaggregation was significantly different from the control 30 min after the drug was administered, and after 1 hr it had reached its maximal effect; the response persisted for at least 4-6 hr (Table 1) .
To determine whether sensitivity to disaggregation by amphetamine might be age-related, 15 mg/kg of amphetamine were injected into rats 7, 21, 26, 40, or 70 days of age. Although this dose produced significant polysome disaggregation in animals 26 days of age or older, the brain polysome profiles of animals 21 days or younger showed no change (Table 2) . However, larger doses of amphetamine (50 mg/kg) disaggregated brain polysomes in 7-to 9-day-old pups.
Since catecholamine-containing brain neurons appear, to mediate many of the behavioral and physiological effects of amphetamine (16) , we examined the extent to which pretreatment with drugs known to block brain dopamine receptors affects the amphetamine-induced disaggregation. Rats 26 days of age were pretreated with haloperidol (20 mg/kg in 1 
DISCUSSION
Many of the acute behavioral and neurochemical effects of amphetamine apparently result from its actions on catecholamine-containing brain neurons (16) . Thus, the release of brain catecholamines into synapses may mediate the amphetamine-induced stereotypy (17, 18), locomotor hyperactivity (6-9), cerebral glycogenolysis (19, 20) , and body temperature changes observed in hot and cold environments (11) (12) (13) (14) . The biochemical mechanisms by which amphetamine may increase intrasynaptic catecholamines include: (a) the enhanced release of cateeholamnines from storage sites; (b) the blockade of re-uptake mechanisms; (c) the inhibition of monoamine oxidase; and (d) the apparent replacement of the catecholamines in storage granules by the amphetamine metabolite parahydroxynorephe-drine (21) (22) (23) . Catecholamine release may also be a factor in toxic responses that occur with very large doses of amphetamine; pretreatment with drugs that block catecholamine receptors (e.g., propranolol, haloperidol, or chloropromazine) may reduce the mortality or the increase in plasma lactic acid concentration that follows massive doses of amphetamine (24) . The present study shows that polyribosomes in rat brain disaggregate shortly after animals receive large doses of d-amphetamine sulfate (10 mg of sulfate per kg or more). This response persists for 4-6 hr; the effective dose varies with the age of the animal. Pretreatment of rats with haloperidol or pimozide, two drugs known to block brain dopamine receptors (25, 26) , also blocks amphetamine-induced polysome disaggregation, suggesting that this effect of amphetamine is mediated by dopamine receptors. This evidence can be interpreted to mean either (a) that amphetamine releases dopamine into synapses and the receptor blocking agents prevent its action on post-synaptic receptors, or (b) that amphetamine has a direct, intracellular action on the protein-synthetic appa- Many parallels exist between the effects of d-amphetamine and -dopa on brain protein synthesis. The disaggregation of brain polyribosomes induced by both drugs occurs within 1 hr of their administration, persists for relatively short periods (iLe., 2 hr for i-dopa and 6 hr for amphetamine), and can be blocked by pretreatment with the dopamine receptor blocking agents, haloperidol and pimozide. On the other hand, while adolescent and mature rats showed brain polysome disaggregation even at low doses of d-amphetamine, infant rats treated before weaning were relatively resistant to the amphetamineinduced disaggregation. These age-dependent changes may reflect ontogenetic changes in synaptogenesis or in the proteinsynthetic mechanisms within individual brain cells. The relative insensitivity of infant rats to amphetamine treatment contrasts with their heightened sensitivity to dopa-induced disaggregation (1 (27) . The time course of the amphetamine-induced polysome disaggregation coincides with those of numerous other behavioral and physiological effects of amphetamine. However, the dosages necessary to achieve polysome disaggregation in whole rat brains are several times greater than those needed to produce some behavioral and physiological effects. It is, of coutse, possible that considerably lower doses of amphetamine might significantly reduce protein synthesis within particular brain regions and that such efects might underlie some of the behavioral, physiological, or toxic effects of this drug. 
